Food Allergies
- Treatment of Multi-Food Allergy with Omalizumab Compared to Omalizumab-Facilitated Multi-Allergen OIT
- Common Allergens
- It’s a Disease, Not a Diet: A documentary about life with food allergies
- Children With Food Allergies
- Living with Food Allergies: Preparing for College
- Omalizumab for the Treatment of Multiple Food Allergies
- Omalizumab Prescribing Information
- Peanut Oral Immunotherapy Prescribing Information
- Clinical Burden of Food Allergies: Insights from the FARE Patient Registry
- Mental Health Burden of Food Allergies: Insights from Patients and Their Caregivers from FARE Patient Registry
- Food Allergies: National Institute of Allergy and Infectious Diseases
- Food Allergy Information from the American College of Allergy, Asthma & Immunology
- Kids With Food Allergies
- FARE powered by Sifter Shopping Tool for Food Allergy Needs
- Managing food allergy: GA2LEN guideline 2022
Asthma
- Dupilumab Prescribing Information
- Tezepelumab Prescribing Information
- Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma
- Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma
- American Lung Association: Severe Asthma
- Mepolizumab Prescribing Information
- National Jewish Health Inhaler Instructional Videos
Chronic Spontaneous Urticaria (CSU)
- Dupilumab in Patients With Chronic Spontaneous Urticaria Phase 3 LIBERTY-CSU CUPID Randomized Clinical Trials
- Remibrutinib in chronic spontaneous urticaria: 52-week results from two phase 3 studies
- The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria
- The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria
- Never Just Hives – Patient Resource
- Chronic spontaneous urticaria and chronic inducible urticaria
- Why fexofenadine is considered as a truly non-sedating antihistamine with no brain penetration: a systematic review
- First-Generation vs Second-Generation H1 Antihistamines for Chronic Urticaria: Systematic Review and Network Meta-Analysis
- Treatment of Recalcitrant Chronic Urticaria With Nonsedating Antihistamines: Is There Evidence for Updosing?
- Efficacy and Safety of Up-dosed Second-generation Antihistamines in Uncontrolled Chronic Spontaneous Urticaria: A Review
- Fexofenadine Prescribing Information
- The efficacy and safety of high-dose nonsedating antihistamines in chronic spontaneous urticaria: a systematic review and meta-analysis of randomized clinical trials
- Management of Chronic Spontaneous Urticaria Made Practical: What Every Clinician Should Know
- Urticaria Voices: Real-World Experience of Patients Living with Chronic Spontaneous Urticaria
- Chronic Spontaneous Urticaria: A Review
- Update on the Treatment of Chronic Spontaneous Urticaria
- Endotypes, phenotypes, and biomarkers in chronic spontaneous urticaria: Evolving toward personalized medicine
- Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials
- Remibrutinib in Chronic Spontaneous Urticaria
- Patient education: Hives (urticaria) (Beyond the Basics)



